Ming Yu seeks a share of the drug sector limelight
Led by a former research chief at drugs giant Hengrui, the Chinese biotech can boast solid credentials and big-name backers as it positions for a Hong Kong IPO Key Takeaways:…
BRIEF: GenFleet shares double in heavily oversubscribed IPO
Shares of biopharmaceutical firm GenFleet Therapeutics (Shanghai) Inc. (2595.HK) opened up 116% in their Hong Kong trading debut on Friday, and held on to the gains to close up more…
Cancer drug maker Genfleet joins Hong Kong IPO influx
The biotech can boast a long list of big-name backers and has brought a promising drug to the market with its partner Innovent, but its cash reserves are dwindling Key…
